AI drug target discovery company co-founded by Namshik Han receives £1.4 million pre-seed investment
CardiaTec, a company co-founded by Milner Head of Computational Biology Dr Namshik Han, has secured £1.4 million pre-seed investment to combat cardiovascular diseases using artificial intelligence (AI). CardiaTec is developing a target discovery platform for analysing...
Deputy Director Kathryn Chapman receives CEO Today Business Women of the Year Award
The CEO Today Business Women of the Year Awards 2022 edition has been published this week, and we’re delighted that Milner Deputy Director Kathryn Chapman has been announced as an awardee. Dedicated to recognising the achievements of today’s female leaders and...
Milner – LifeArc strategic partnership extended for five years
We are thrilled to announce that the Milner collaboration with the medical research charity LifeArc has been expanded into a 5-year strategic partnership until 2026. The Milner Computational Research team, led by Namshik Han, have been collaborating closely with the...
Milner Institute wins award for innovation at Cambridge Independent Science and Technology Awards
We are honoured to have been announced as highly commended in the Innovation category of the 2022 Cambridge Independent Science & Technology Awards. Milner Director Kathryn Chapman was presented with the trophy at the awards ceremony held last night. Several...